---
title: How I Treat Anemia in Myelofibrosis
date: '2025-01-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39808793/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20250115170812&v=2.18.0.post9+e462414
source: Blood
description: Anemia is a common consequence of myelofibrosis. The treatment of myelofibrosis-associated
  anemia is complicated by a multifactorial pathobiology, as well as a lack of therapies
  that result in normalization of the bone marrow and complete restoration of its
  function. Established agents that are used to treat anemia in other bone marrow
  failure states such as myelodysplastic syndromes and aplastic anemia, are used for
  the treatment of myelofibrosis-associated anemia. However, there has been ...
disable_comments: true
---
Anemia is a common consequence of myelofibrosis. The treatment of myelofibrosis-associated anemia is complicated by a multifactorial pathobiology, as well as a lack of therapies that result in normalization of the bone marrow and complete restoration of its function. Established agents that are used to treat anemia in other bone marrow failure states such as myelodysplastic syndromes and aplastic anemia, are used for the treatment of myelofibrosis-associated anemia. However, there has been ...